Abstract:OBJECTIVE:To investigate the pathogen profile of nosocomial infection in China, and to survey the susceptibility rates of these pathogens to the clinical common antibiotics.METHODS:The non-repetitive nosocomial pathogens isolated from bloodstream infection (BSI), hospital acquired pneumonia (HAP) and intra-abdominal infection (IAI) and the case data were collected from 13 teaching hospitals in different areas of China and sent to a central laboratory for re-identification and susceptibility testing. The levels of minimal inhibitory concentration (MIC) of the common antibiotics were determined by agar dilution method. The data were analyzed by WHONET 5.6 software.RESULTS:A total of 2103 clinical isolates were collected from January to December 2011, of which gram positive cocci and gram negative organisms accounted for 23.2% and 76.8% respectively. The top three pathogens of BSI were E. coli (31.0%, 243/784), K. pneumoniae (14.8%, 116/784) and S. aureus (10.6%, 83/784). The top three pathogens of HAP were A. baumannii (24.2%, 158/652), P. aeruginosa (23.0%, 150/652) and K. pneumoniae (16.4%, 107/652). The top three pathogens of IAI were E. coli (34.3%, 229/667), E. faecium (13.3%, 89/667) and K. pneumoniae (9.6%, 64/667). Methicillin-resistant S. aureus (MRSA) and coagulase negative Staphylococcus (MRCNS) accounted for 64.4% and 78.1% respectively. The susceptibility rates of Staphylococcus species to tigecycline, vancomycin, teicoplanin and linezolid were all 100%. The prevalence of MRSA in HAP was significantly higher than that in BSI or IAI. The susceptibility rates of Enterococcus species to tigecycline, teicoplanin and linezolid were all 100%. The prevalence of extended-spectrum β-lactamases (ESBL) was 64.3% in E. coli and 38.3% in K. pneumonia. Against Enterobacteriaceae, the most active agents were as following in order: tigecycline (92.3% - 100%) [except P.mirabilis], meropenem (87.5% - 100%), imipenem (87.5% - 100%) [except M. morganii], amikacin (87.5% - 100%), polymyxin B (75% - 100%) [except S. marcescens, P. mirabilis and M morganii], cefepime (67.8% - 100%), cefoperazone-sulbactam (66.6% - 100%), piperacillin-tazobactam (61.5% - 100%). Carbapenem-resistance Enterobacteriaceae strains emerged. The susceptibility rates of P. aeruginosa to imipenem and meropenem were 66.2% and 72.2%, respectively. The susceptibility rates of A. baumannii to imipenem and meropenem were 27.7% and 25.9%, respectively. The most active agents against A. baumannii were polymyxin B (100%), followed by tigecycline (79.8%) and minocycline (50.4%). The susceptibility rates of P.aeruginosa to antibiotics in BSI were higher than those in HAP and IAI. Susceptibility rates of S. maltophilia to trimethoprim-sulfamethoxazole, minocycline and levofloxacin were about 90% or above. Susceptibility rates of B. cepacia to trimethoprim-sulfamethoxazole, ceftazidime and meropenem were all 100%. Several P.aeruginosa and A. baumannii strains were resistant to all tested antibiotics except polymyxin B.CONCLUSIONS:The pathogen profile is different in different types of infection. The prevalence of multi-drug resistant A. baumannii is high, which is still a key problem of nosocomial infection. Tigecycline remains relatively high activity against gram-positive cocci and gram-negative bacteria (except P. aeruginosa and P. mirabilis) in vitro.

Antimicrobial Susceptibility of Multi-drug Resistant Acinetobacter Baumannii and Pseudomonas Aeruginosa Isolates from 27 Hospitals in China

Antimicrobiai Resistance Surveillance on Hospital-and Community-acquired Pathogens in 10 Teaching Hospitals in China

Antimicrobial Susceptibilitytesting of Non-Fermentative Bacteria in 15 Teaching Hospitals in China: a Report from SEANIR Antimicrobial Resistance Surveillance 2008

[Surveillance of Antimicrobial Resistance among Nosocomial Gram-Negative Pathogens from 15 Teaching Hospitals in China in 2005].

Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013

Detection of 22 beta-lactamase genes and enzyme activities in multi-drug resistant Acinetobacter baumannii

Sample cluster analysis of resistance genes in multidrug-resistant Acinetobacter baumannii

Resistance of the Carbapenems and Homology Analysis of Pseudomonas Aeruginosa in 28 Hospitals in China

Antimicrobial resistance of Acinetobacter baumanii in ICU

[An Analysis of Resistance of Nosocomial Infection Pathogens Isolated from 13 Teaching Hospitals in 2011].

[Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].

Antimicrobial resistance surveillance among pathogens causing nosocomial bloodstream infection, pneumoniae and intra-abdominal infection at 14 teaching hospitals in China

A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii

Antimicrobial susceptibility and genetic characteristics of multi-drug resistant Acinetobacter baumannii isolates in Northwest China

Analysis of antimicrobial resistance of multidrug resistant Pseudomonas aeruginosa

CHINET 2012 surveillance of antibiotic resistance in Acinetobacter baumannii isolates in China

Analysis of Pathogen Spectrum and Antimicrobial Resistance of Pathogens Associated with Hospital-Acquired Infections Collected from 11 Teaching Hospitals in 2018

Sources of Multidrug-Resistant Acinetobacter Baumannii and Its Role in Respiratory Tract Colonization and Nosocomial Pneumonia in Intensive Care Unit Patients.

Survey on multi-resistant Acinetobacter baumannii infection and analysis of drug susceptibility

Molecular Epidemiology of Multi-Drug Resistant Acinetobacter baumannii Isolated in Shandong, China

[Analysis of Pathogen Spectrum and Resistance of Clinical Common Organisms Causing Bloodstream Infections, Hospital-Acquired Pneumonia and Intra-Abdominal Infections from Thirteen Teaching Hospitals in 2013].